





























YAM ：若年成人平均値（20 ～4 歳）
骨塩量値
YAM の80 % ～70%




骨萎縮とは radiographic ostepnia に相当する。


















































分類8) （表 4 ）では I型（閉経後骨粗繋症）に対して II
壊血病




























































































































































































































尿中 ・血清 N 端テロペプチド（NTx )
血清 C 端テロペプチド（ICTP )
尿中 C 端テロペプチド断片 （CrosLa ps TM) 
破骨細胞産物
血禁酒石酸抵抗性酸ホスフ ァターゼ （TRAP )
骨形成マーカマ
血清骨型アルカリホス ファターゼ （B-ALP )
血清オステオカルシン（BGP )

















吸収マーカーと，骨芽細胞産物を主とする骨形成マー ・ 述のピリジノリン架橋はコラーゲンの N および C 末端







解産物である尿中 C 端テロペプチド断片（Croslaps ™ ) 
は種々の骨代謝異常において骨吸収マーカーとしての有




















IRMA 法や EIA 法により測定される。オステオカルシ
ンは49 個のアミノ酸からなる骨特異的な基質蛋白で，ビ
タミン K 依存的に yーカルボキシル化されるグルタミ







端（PIN), C 端（PICP ）のペプチド断片である。と
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Pathogenesis and pathophysiology of osteoporosis 
Daisuke Inoue 
First Department of Internal Medicine, The University of Tokushima School of Medicine, Tokushima 
SUMMARY 
Osteoporosis is a multifactorial disease characterized by low bone mineral density 
(BMD) and disorganized bone microarchitecture with increased probability for fratures. 
Substantial evidence obtained from gentic, biochemical and epidemiological analyses has 
identified a great number of genetic or environmental risk factors for osteoporosis. Identifi-
cation of genetically high-risk patients and elimination of environmental risks is clinically 
important for prevention and treatment of osteoporosis especially from an economical point 
of view. 
Osteoporosis is also multifactorial and complex in terms of pathophysiology, which often 
complicates its treatment. The disease is currently classified into two categories: primary 
osteoporosis including postmenopausal and senile osteoporosis ; and secondary osteoporosis 
caused by various diseases such as endocrinological, nutritional and metabolic disorders. 
Understanding of the pathophysiology of osteoporosis is critical to effective treatment. 
Deveopment of metabolic markers has enabled us to routinely analyze turnover of bone 
which is subject to continuous remodeling and to predict bone mass changes in the future. 
This review focuses on the recent progress in understanding of the pathogenesis and 
the pathophysiology of osteoporosis. 
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